Original paper

Omadacycline: A Novel Oral and Intravenous Aminomethylcycline Antibiotic Agent

Drugs11.50
Volume: 80, Issue: 3, Pages: 285 - 313
Published: Jan 22, 2020
Abstract
Omadacycline is a novel aminomethylcycline antibiotic developed as a once-daily, intravenous and oral treatment for acute bacterial skin and skin structure infection (ABSSSI) and community-acquired bacterial pneumonia (CABP). Omadacycline, a derivative of minocycline, has a chemical structure similar to tigecycline with an alkylaminomethyl group replacing the glycylamido group at the C-9 position of the D-ring of the tetracycline core. Similar...
Paper Details
Title
Omadacycline: A Novel Oral and Intravenous Aminomethylcycline Antibiotic Agent
Published Date
Jan 22, 2020
Journal
Volume
80
Issue
3
Pages
285 - 313
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.